Short Term Gestation and Long Term Risk. Premature CKD Pediatrics.
Short Term Gestation and Long Term Risk. Premature CKD Pediatrics.
Short Term Gestation and Long Term Risk. Premature CKD Pediatrics.
Improving survival for the smallest, hypertension,10 insulin resistance,11 and hypertension and proteinuria.14,16–18 These
most vulnerable infants is among the coronary artery disease.12 processes eventually cause nephrons
great success stories in pediatrics. The Nephrologist Barry Brenner first applied to become sclerotic and senescent.
advances in neonatal intensive care in Barker’s theory to the development of This in turn leads to additional decline
the past 50 years have been nothing less CKD. Building on the observation that in nephron number and greater hyper-
than remarkable: according to the most human nephron number is widely vari- filtration in remnant nephrons, culmi-
recent data from the Vermont Oxford able (ranging from 200 000 to 2 million nating in more rapid nephron dropout
Network, ∼90% of infants born weigh- per kidney13), Brenner hypothesized and perpetuating renal injury in a vicious
ing 501 to 1500 g survive to NICU dis- that either a congenital or acquired re- cycle14,19 (Fig 1).
charge, and ∼60% of survivors leave duction in nephron number could ex-
the NICU without any major neonatal plain why some individuals are more LATE GESTATION IS CRITICAL FOR
morbidity.1 It is clear that today, many susceptible to hypertension and CKD.14 NEPHROGENESIS
infants who in another era would have
Brenner proposed that persons with Although nephrogenesis in humans
died within a matter of hours are now
a decreased complement of nephrons begins around 9 weeks gestation,20,21
surviving to adulthood.
can initially maintain a normal glo- 60% of nephrons are formed during the
The long-term consequences of pre- merular filtration rate (GFR) as in- third trimester (Fig 2).22 The entire
maturity or low birth weight (LBW) are dividual nephrons enlarge to increase nephron complement of the human
less clear. Although there has been a the total surface area available for re- kidney is determined by 36 weeks’ ges-
great deal of research into the neuro- nal work.15 Over time, however, this tation,23 and these nephrons must last
developmental outcomes of premature adaptive response becomes harmful. for a lifetime because nephrons do not
infants,2–4 the impact of prematurity or Increased glomerular surface area have the ability to regenerate24; even in
LBW on other organ systems is less well leads to sodium retention and systemic healthy persons, the number of func-
understood. There is now evidence from hypertension, and glomerular hyper- tional nephrons gradually declines over
both the basic science and the clinical filtration disrupts renal autoregulatory time, leading to the age-dependent de-
arenas to suggest that premature and mechanisms, generating intraglomerular cline in GFR seen in older adults.25
LBW infants who survive the NICU still
face serious risks to their long-term
kidney health. Here, we review the the-
ory, experimental evidence, and obser-
vational data that suggest an increased
risk of chronic kidney disease (CKD) for
premature and LBW infants and argue
for increased surveillance of these
patients.
such as socioeconomic status in ret- tional ages of 22 to 30 weeks, and pre- authors even to suggest that the rising
rospective studies, a systematic review sented at an average age of 32 years incidence of AKI may be partly re-
of 31 cohort or case-control studies with nephrotic-range proteinuria, hypo- sponsible for the nationwide increase
found a 70% increase in adulthood CKD albuminemia, and lack of edema without in CKD and ESRD.61 A recent meta-
for LBW infants.46 Although this meta- other risk factors for secondary FSGS. analysis of adult trials found a sub-
analysis excluded studies consisting stantial, exposure-dependent risk of
exclusively of extremely LBW or very CKD after AKI, with patients who expe-
premature infants, other more inclusive AKI AS A RISK FACTOR FOR CKD rienced more severe AKI developing
studies have shown similar results. A Acute kidney injury in the NICU is CKD and ESRD more frequently.62 Al-
national registry-based study including common. Although its overall incidence though there are inherent risks in ex-
all infants born in Norway from 1967 to is difficult to determine given the lack of trapolating the results of adult studies
2004 found an overall relative risk of 1.7 multicenter studies and variable defi- to pediatric patients, it seems likely that
for the development of end-stage renal nitions of AKI, it is clear that smaller and nephron loss would have even greater
disease (ESRD) for infants with birth sicker infants most commonly experi- effects on future health for a newborn
weight ,10th percentile compared with ence AKI (Table 1). Yet because the infant than for an older adult.
those with weights from the 10th to 90th majority of pediatric patients with AKI Moreover, the limited number of pedi-
percentile.47 are discharged from the hospital with atric studies have found similar results.
Clinical signs of oligonephropathy a normal serum creatinine,55 the long- Pediatric patients with AKI due to
among patients born prematurely may term significance of their renal injury diarrhea-associated hemolytic-uremic
be detectable in childhood.48,49 Two may not be appreciated. syndrome,63 meningococcal sepsis,64
recent case series (each including 50 It was long taught that AKI is reversible.56 and cardiac surgery65 all have an in-
infants born at ,30–32 weeks’ gesta- This may be true for AKI caused purely creased long-term risk of CKD. Beyond
tion) found that children born pre- by volume depletion, but it is now clear these specific populations, a recent
maturely had smaller kidneys and that intrinsic forms of AKI cause cumu- single-center PICU study found that
higher blood pressure compared lative and irreversible damage. In ani- 10.3% of all patients with AKI (defined
with term controls, even though their mal models of acute tubular necrosis, by Acute Kidney Injury Network crite-
GFR remained normal.50,51 Microalbu- renal regeneration is not complete: ria66) subsequently developed CKD
minuria, an early indicator of kidney there is permanent reduction in vascu- (GFR ,60 mL/min/1.73 m2) within the
disease and a risk factor for future lar density and compromised oxygen next 1 to 3 years.67 An additional 46.8%
cardiovascular morbidity,52 is also com- delivery.57,58 Regeneration of tubular of this cohort were deemed “at risk”
mon among children aged 8 to 11 years epithelial cells can result in sustained for CKD based on the presence of hy-
who were born prematurely or with fibroblast activation, leading to pro- pertension, reduced GFR (60–90 mL/
LBW.53 gressive fibrosis even after the initial min/1.73 m2), or hyperfiltration (GFR
The first series of premature infants insult has subsided.59,60 .150 mL/min/1.73 m2).
who developed secondary FSGS was There is now ample epidemiologic These studies have been criticized for
recently reported.54 These 6 patients evidence associating AKI with the epidemiologic flaws that prevent the
were all very premature, with gesta- development of CKD, leading some determination of causation; that is, it
FIGURE 3
Follow up strategies for NICU graduates. In the absence of high-quality evidence, physicians must make an individualized risk assessment of each patient and
balance the risks and benefits of any screening strategy. IUGR, intrauterine growth retardation; SGA, small for gestational age.
a prospective cohort of patients with all nucleated cells,85 is more easily in- children or adolescents, competing
mild to moderate CKD, independent of terpretable than creatinine because factors such as patient size, compen-
GFR.77 a single reference range can be used satory hypertrophy of remnant neph-
Assessments of the NICU graduate for any child over 1 year of age.86 Cys- rons, and additional nephron loss
should continue into adolescence, a time tatin C is a more sensitive marker of through injury make the relationship
when many children see their pediatri- mild renal impairment than creati- between kidney size and nephron
cian less frequently. Rapid growth in nine,87,88 and mild elevations are seen number less easily interpretable.99 Al-
puberty often unmasks renal dysfunc- in preterm infants at 12 to 36 months of though some studies have found
tion78 because abnormal kidneys may age compared with term control sub- smaller renal length or volume in
be unable to accommodate the de- jects.89 However, this test is expensive children born prematurely,100 the use
mands of increased growth. It is also and not readily available in all areas. of ultrasound or other imaging tech-
important that adolescent patients, Microalbuminuria (urine albumin/ niques is expensive and has yet to be
particularly those nearing transition to creatinine of 30–300 mg/g) is also an validated prospectively.
adult practitioners, be aware of their early indicator of CKD and represents
history of prematurity, understand their a therapeutic target for CKD progres- INTERVENTION AND EDUCATION
increased long-term risk for CKD, and sion.90 Standard urine dipsticks detect
Any recommendation for increased
receive counseling regarding modifi- only overt albuminuria, but targeted
population-based screening must be
able risk factors for CKD progression screening of premature or LBW infants
tempered by the acknowledgment that
(such as smoking,79 hypertension,80 or could result in earlier detection of CKD.
there is no specific therapy to slow or
obesity81). Such screening is already standard of
arrest the progression of CKD in chil-
Laboratory tests may be useful in specific care in certain other high-risk groups,
dren born prematurely or with a LBW.101
circumstances. Whereas an abnormal such as children with type 1 diabetes
However, there are nonspecific thera-
serum creatinine at NICU discharge or in mellitus91 and sickle cell disease.92
peutic targets for CKD progression
childhood carries an ominous prognosis, Unfortunately, the utility of micro-
such as hypertension,101,102 microalbu-
serum creatinine is not a sensitive in- albuminuria as a screening tool may be minuria,90 and dyslipidemia.90 In partic-
dicator of long-term CKD risk because hampered by a high false-positive rate ular, inhibition of the renin-angiotensin
increased tubular secretion can main- due to the prevalence of benign protei- system (RAS) has been shown to slow
tain a normal plasma creatinine until nurias (such as orthostatic proteinuria93 CKD progression in adults with pro-
25% to 50% of GFR has been lost.82 or exercise-induced proteinuria94) in the teinuria103 and hypertensive children
Pediatricians and neonatologists must pediatric population. For example, in aged 3 to 18104 and is standard of care in
therefore not be falsely reassured by the NHANES, 8.9% of adolescents had nephropathy related to diabetes.105,106
normal values. Additionally, the recogni- microalbuminuria, although the majority However, these medications must be
tion of mildly abnormal creatinine values of these had no other risk factors for used cautiously in children because
in children may be challenging. Although cardiovascular or renal disease.95 Find- their side-effect profile is not benign,
the average creatinine for a 2-year-old is ing elevated levels would therefore re- and they are a well-described cause of
0.3 mg/dL,83 values up to 0.6 mg/dL are quire additional testing to distinguish AKI, particularly with volume depletion
often reported as normal by reference true disease from benign proteinuria. or when given in combination with
laboratories.84 Yet these “normal” values Screening patients with imaging tech- other medications that decrease renal
can reflect significantly impaired GFR, as niques such as renal ultrasound is blood flow.107
demonstrated in Table 2. theoretically appealing because renal Even in the absence of targeted thera-
Cystatin C, a nonglycosylated basic volume at birth is a surrogate for pies for CKD progression, earlier
protein produced at a constant rate by nephron number.96–98 However, in older identification of patients with CKD could
provide the opportunity to improve
TABLE 2 Estimates of GFR With “Normal” Creatinine Values for a Hypothetical 2-Year-Old Child patient outcomes by addressing sys-
With Height 86.4 cm Using the Revised Schwartz Equationa
temic complications of CKD sooner.
Serum Creatinine (mg/dL) Estimated GFR (mL/min/1.73 m2) Interpretation148,150
Beyond the well-known complications
0.3 119 Normal of CKD such as anemia, poor growth,
0.4 89 Normal
0.5 71 Stage 2 CKD and renal osteodystrophy, many chil-
0.6 59 Stage 3 CKD dren with CKD have impaired neuro-
a GFR = 0.413 3 height(cm) / creatinine(mg/dL).148 cognitive function and reduced quality
REFERENCES
1. Horbar JD, Carpenter JH, Badger GJ, et al. 5. Barker DJ, Martyn CN. The fetal origins of 11. Barker DJ. The developmental origins of
Mortality and neonatal morbidity among hypertension. Adv Nephrol Necker Hosp. insulin resistance. Horm Res. 2005;64
infants 501 to 1500 grams from 2000 to 1997;26:65–72 (suppl 3):2–7
2009. Pediatrics. 2012;129(6):1019–1026 6. Barker DJ. Sir Richard Doll Lecture. De- 12. Barker DJ. Fetal origins of coronary heart
2. Hack M, Taylor HG, Drotar D, et al. Poor velopmental origins of chronic disease. disease. BMJ. 1995;311(6998):171–174
predictive validity of the Bayley Scales of Public Health. 2012;126(3):185–189 13. Hoy WE, Hughson MD, Bertram JF, Douglas-
Infant Development for cognitive function of 7. Langley-Evans SC. Developmental pro- Denton R, Amann K. Nephron number,
extremely low birth weight children at gramming of health and disease. Proc hypertension, renal disease, and renal
school age. Pediatrics. 2005;116(2):333–341 Nutr Soc. 2006;65(1):97–105 failure. J Am Soc Nephrol. 2005;16(9):2557–
3. Hack M, Flannery DJ, Schluchter M, Cartar 8. Chong E, Yosypiv IV. Developmental pro- 2564
L, Borawski E, Klein N. Outcomes in young gramming of hypertension and kidney 14. Brenner BM, Garcia DL, Anderson S. Glo-
adulthood for very-low-birth-weight in- disease. Int J Nephrol. 2012;2012:760580 meruli and blood pressure. Less of one,
fants. N Engl J Med. 2002;346(3):149–157 9. Desai M, Beall M, Ross MG. Developmental more the other? Am J Hypertens. 1988;1(4
4. Wilson-Costello D, Friedman H, Minich N, origins of obesity: programmed adipo- pt 1):335–347
Fanaroff AA, Hack M. Improved survival genesis. Curr Diab Rep. 2013;13(1):27–33 15. Luyckx VA, Brenner BM. Low birth weight,
rates with increased neurodevelopmental 10. Barker DJ, Osmond C, Forsen TJ, Kajantie nephron number, and kidney disease.
disability for extremely low birth weight E, Eriksson JG. Maternal and social ori- Kidney Int Suppl. 2005;97:S68–S77
infants in the 1990s. Pediatrics. 2005;115 gins of hypertension. Hypertension. 2007; 16. Brenner BM, Chertow GM. Congenital oli-
(4):997–1003 50(3):565–571 gonephropathy and the etiology of adult
ischemic injury: effects of L-arginine on 70. Kripalani S, LeFevre F, Phillips CO, Williams 82. Shemesh O, Golbetz H, Kriss JP, Myers BD.
hypoxia and secondary damage. Am J MV, Basaviah P, Baker DW. Deficits in Limitations of creatinine as a filtration
Physiol Renal Physiol. 2003;284(2):F338– communication and information transfer marker in glomerulopathic patients. Kid-
F348 between hospital-based and primary care ney Int. 1985;28(5):830–838
58. Basile DP, Donohoe D, Roethe K, Osborn JL. physicians: implications for patient safety 83. Pottel H, Mottaghy FM, Zaman Z, Martens
Renal ischemic injury results in permanent and continuity of care. JAMA. 2007;297(8): F. On the relationship between glomerular
damage to peritubular capillaries and 831–841 filtration rate and serum creatinine in
influences long-term function. Am J Physiol 71. Carmody J, Swanson J, Rhone E, Charlton children. Pediatr Nephrol. 2010;25(5):927–
Renal Physiol. 2001;281(5):F887–F899 J. Acute kidney injury incidence and 934
59. Bechtel W, McGoohan S, Zeisberg EM, et al. follow-up in very low birth weight infants. 84. Savory DJ. Reference ranges for serum
Methylation determines fibroblast activa- Presented at the Pediatric Academic So- creatinine in infants, children and ado-
tion and fibrogenesis in the kidney. Nat cieties Annual Meeting; Washington, DC; lescents. Ann Clin Biochem. 1990;27(pt 2):
Med. 2010;16(5):544–550 May 4–7, 2013 99–101
60. Yang L, Besschetnova TY, Brooks CR, Shah 72. Keller G, Zimmer G, Mall G, Ritz E, Amann 85. Coll E, Botey A, Alvarez L, et al. Serum
JV, Bonventre JV. Epithelial cell cycle ar- K. Nephron number in patients with pri- cystatin C as a new marker for non-
rest in G2/M mediates kidney fibrosis af- mary hypertension. N Engl J Med. 2003; invasive estimation of glomerular filtra-
ter injury. Nat Med. 2010;16(5):535–543 348(2):101–108 tion rate and as a marker for early renal
73. Hagan J, Shaw J, Duncan P, eds. Bright impairment. Am J Kidney Dis. 2000;36(1):
61. Hsu CY. Linking the population epidemiol-
Futures: Guidelines for Health Supervision 29–34 doi:10.1053/ajkd.2000.8237
ogy of acute renal failure, chronic kidney
of Infants, Children, and Adolescents. 3rd 86. Finney H, Newman DJ, Thakkar H, Fell JM,
disease and end-stage renal disease. Curr
ed. Elk Grove Village, IL: The American Price CP. Reference ranges for plasma
Opin Nephrol Hypertens. 2007;16(3):221–
Academy of Pediatrics; 2008 cystatin C and creatinine measurements
22
74. Bonamy AK, Kallen K, Norman M. High in premature infants, neonates, and older
62. Coca SG, Singanamala S, Parikh CR.
blood pressure in 2.5-year-old children children. Arch Dis Child. 2000;82(1):71–75
Chronic kidney disease after acute kidney
born extremely preterm. Pediatrics. 2012; 87. Dharnidharka VR, Kwon C, Stevens G. Se-
injury: a systematic review and meta-
129(5). Available at: www.pediatrics.org/ rum cystatin C is superior to serum cre-
analysis. Kidney Int. 2012;81(5):442–448
cgi/content/full/129/5/e1199 atinine as a marker of kidney function:
63. Garg AX, Suri RS, Barrowman N, et al. Long-
75. Mahesh S, Kaskel F. Growth hormone axis a meta-analysis. Am J Kidney Dis. 2002;40
term renal prognosis of diarrhea-associated
in chronic kidney disease. Pediatr Neph- (2):221–226
hemolytic uremic syndrome: a systematic
rol. 2008;23(1):41–48 88. Roos JF, Doust J, Tett SE, Kirkpatrick CM.
review, meta-analysis, and meta-regression.
76. Kleinknecht C, Broyer M, Huot D, Marti- Diagnostic accuracy of cystatin C com-
JAMA. 2003;290(10):1360–1370
Henneberg C, Dartois AM. Growth and pared to serum creatinine for the esti-
64. Slack R, Hawkins KC, Gilhooley L, Addison mation of renal dysfunction in adults and
development of nondialyzed children with
GM, Lewis MA, Webb NJ. Long-term out- children—a meta-analysis. Clin Biochem.
chronic renal failure. Kidney Int Suppl.
come of meningococcal sepsis-associated 1983;15:S40–S47 2007;40(5-6):383–391
acute renal failure. Pediatr Crit Care Med.
77. Greenbaum LA, Munoz A, Schneider MF, 89. Carballo-Magdaleno D, Guizar-Mendoza
2005;6(4):477–479
et al. The association between abnormal JM, Amador-Licona N, Dominguez-Dominguez
65. Shaw NJ, Brocklebank JT, Dickinson DF, birth history and growth in children with V. Renal function, renal volume, and blood
Wilson N, Walker DR. Long-term outcome CKD. Clin J Am Soc Nephrol. 2011;6(1): pressure in infants with antecedent of
for children with acute renal failure fol- 14–21 antenatal steroids. Pediatr Nephrol. 2011;
lowing cardiac surgery. Int J Cardiol. 26(10):1851–1856
78. Ardissino G, Daccò V, Testa S, et al; ItalKid
1991;31(2):161–165 90. Taal MW, Brenner BM. Renal risk scores:
Project. Epidemiology of chronic renal
66. Mehta RL, Kellum JA, Shah SV, et al; Acute failure in children: data from the ItalKid progress and prospects. Kidney Int. 2008;
Kidney Injury Network. Acute Kidney Injury project. Pediatrics. 2003;111(4 pt 1). 73(11):1216–1219
Network: report of an initiative to improve Available at: www.pediatrics.org/cgi/con- 91. Silverstein J, Klingensmith G, Copeland K,
outcomes in acute kidney injury. Crit Care. tent/full/111/4pt1/e382 et al; American Diabetes Association. Care
2007;11(2):R31 79. Orth SR, Hallan SI. Smoking: a risk factor of children and adolescents with type 1
67. Mammen C, Al Abbas A, Skippen P, et al. for progression of chronic kidney disease diabetes: a statement of the American
Long-term risk of CKD in children surviv- and for cardiovascular morbidity and Diabetes Association. Diabetes Care. 2005;
ing episodes of acute kidney injury in the mortality in renal patients—absence of 28(1):186–212
intensive care unit: a prospective cohort evidence or evidence of absence? Clin J 92. Rees DC, Williams TN, Gladwin MT. Sickle-
study. Am J Kidney Dis. 2012;59(4):523–530 Am Soc Nephrol. 2008;3(1):226–236 doi: cell disease. Lancet. 2010;376(9757):2018–
doi:1 10.2215/CJN.03740907 2031
68. Rifkin DE, Coca SG, Kalantar-Zadeh K. Does 80. VanDeVoorde RG, Mitsnefes MM. Hyper- 93. Brandt JR, Jacobs A, Raissy HH, et al. Or-
AKI truly lead to CKD? J Am Soc Nephrol. tension and CKD. Adv Chronic Kidney Dis. thostatic proteinuria and the spectrum of
2012;23(6):979–984 2011;18(5):355–361 diurnal variability of urinary protein ex-
69. Beck S, Wojdyla D, Say L, et al. The 81. Chalmers L, Kaskel FJ, Bamgbola O. The cretion in healthy children. Pediatr
worldwide incidence of preterm birth: role of obesity and its bioclinical corre- Nephrol. 2010;25(6):1131–1137
a systematic review of maternal mortality lates in the progression of chronic kidney 94. Poortmans JR. Postexercise proteinuria in
and morbidity. Bull World Health Organ. disease. Adv Chronic Kidney Dis. 2006;13 humans. Facts and mechanisms. JAMA.
2010;88(1):31–38 (4):352–364 1985;253(2):236–240
136. Askenazi DJ, Montesanti A, Hunley H, et al. 142. Koralkar R, Ambalavanan N, Levitan EB, outcome measures, animal models, fluid
Urine biomarkers predict acute kidney McGwin G, Goldstein S, Askenazi D. Acute therapy and information technology needs:
injury and mortality in very low birth kidney injury reduces survival in very low the Second International Consensus Con-
weight infants. J Pediatr. 2011;159(6):907– birth weight infants. Pediatr Res. 2011;69 ference of the Acute Dialysis Quality Initia-
912.e1 (4):354–358 tive (ADQI) Group. Crit Care. 2004;8(4):
137. Schreuder MF, Bueters RR, Huigen MC, 143. Selewski DT, Jordan BK, Askenazi DJ, R204–R212
Russel FG, Masereeuw R, van den Heuvel Dechert RE, Sarkar S. Acute kidney injury 148. Schwartz GJ, Munoz A, Schneider MF, et al.
LP. Effect of drugs on renal development. in asphyxiated newborns treated with New equations to estimate GFR in children
Clin J Am Soc Nephrol. 2011;6(1):212–217 therapeutic hypothermia. J Pediatr. 2013; with CKD. J Am Soc Nephrol. 2009;20(3):
162(4):725–729 629–637
138. Schreuder MF, Nauta J. Prenatal pro-
gramming of nephron number and blood 144. Kaur S, Jain S, Saha A, et al. Evaluation of 149. National Kidney Foundation. K/DOQI clini-
glomerular and tubular renal function in
pressure. Kidney Int. 2007;72(3):265–268 cal practice guidelines for chronic kidney
neonates with birth asphyxia. Ann Trop
139. Beeman SC, Georges JF, Bennett KM. Tox- disease: evaluation, classification, and
Paediatr. 2011;31(2):129–134
icity, biodistribution, and ex vivo MRI de- stratification. Am J Kidney Dis. 2002;39(2
145. Blinder JJ, Goldstein SL, Lee VV, et al. Con-
tection of intravenously injected cationized suppl 1):S1–S266
genital heart surgery in infants: effects of
ferritin. Magn Reson Med. 2013;69(3):853– acute kidney injury on outcomes. J Thorac 150. Tschudy MM, Arcara KM; Johns Hopkins
861 Cardiovasc Surg. 2012;143(2):368–374 Hospital. Children’s Medical and Surgical
140. Beeman SC, Zhang M, Gubhaju L, et al. Center. The Harriet Lane Handbook. 19th
146. Gadepalli SK, Selewski DT, Drongowski RA,
Measuring glomerular number and size in Mychaliska GB. Acute kidney injury in ed. Philadelphia, PA: Mosby Elsevier; 2012
perfused kidneys using MRI. Am J Physiol congenital diaphragmatic hernia re- 151. Brenner BM, Lawler EV, Mackenzie HS. The
Renal Physiol. 2011;300(6):F1454–F1457 quiring extracorporeal life support: an hyperfiltration theory: a paradigm shift in
141. Viswanathan S, Manyam B, Azhibekov T, insidious problem. J Pediatr Surg. 2011;46 nephrology. Kidney Int. 1996;49(6):1774–
Mhanna MJ. Risk factors associated with (4):630–635 1777
acute kidney injury in extremely low birth 147. Bellomo R, Ronco C, Kellum JA, Mehta RL, 152. Cebrián C, Borodo K, Charles N, Herzlinger
weight (ELBW) infants. Pediatr Nephrol. Palevsky P; Acute Dialysis Quality Initiative DA. Morphometric index of the developing
2012;27(2):303–311 workgroup. Acute renal failure - definition, murine kidney. Dev Dyn. 2004;231(3):601–608
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://pediatrics.aappublications.org/content/131/6/1168.full.html